Overview

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
Evaluation of headache response at 2 hours for active treated attacks for increasing dose.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Eletriptan